Cargando…

RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo

Detalles Bibliográficos
Autores principales:	Jyotsana, Nidhi, Sharma, Amit, Chaturvedi, Anuhar, Scherr, Michaela, Kuchenbauer, Florian, Sajti, Laszlo, Barchanski, Annette, Lindner, Robert, Noyan, Fatih, Sühs, Kurt-Wolfram, Grote-Koska, Denis, Brand, Korbinian, Vornlocher, Hans-Peter, Stanulla, Martin, Bornhauser, Beat, Bourquin, Jean-Pierre, Eder, Matthias, Thol, Felicitas, Ganser, Arnold, Humphries, R. Keith, Ramsay, Euan, Cullis, Pieter, Heuser, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702262/ https://www.ncbi.nlm.nih.gov/pubmed/28827563 http://dx.doi.org/10.1038/leu.2017.269

Ejemplares similares

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
por: Mohanty, Sagarajit, et al.
Publicado: (2020)

Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy
por: Yang, Min, et al.
Publicado: (2017)

In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site
por: Chaturvedi, Anuhar, et al.
Publicado: (2019)

Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia
por: Sharma, Amit, et al.
Publicado: (2020)

Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators
por: Qiu, Jinsong, et al.
Publicado: (2016)

Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
por: Kloos, Arnold, et al.
Publicado: (2020)

Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
por: Kloos, Arnold, et al.
Publicado: (2021)

Treatment of Relapsed Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2020)

Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia
por: Chaturvedi, Anuhar, et al.
Publicado: (2020)

IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis
por: Kattih, Badder, et al.
Publicado: (2020)

Treatment for Relapsed/Refractory Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2021)

VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
por: Sethi, Maya K., et al.
Publicado: (2017)

Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
por: Gupta, Charu, et al.
Publicado: (2020)

Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
por: Feurstein, Simone, et al.
Publicado: (2018)

Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion
por: Schneider, Jessica, et al.
Publicado: (2022)

A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation
por: Yang, Min, et al.
Publicado: (2021)

Histiocytic sarcoma progressing from follicular lymphoma and mimicking acquired hemophagocytic lymphohistiocytosis
por: Schünemann, Christoph, et al.
Publicado: (2020)

MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
por: Teich, Katrin, et al.
Publicado: (2023)

Injection of ligand-free gold and silver nanoparticles into murine embryos does not impact pre-implantation development
por: Taylor, Ulrike, et al.
Publicado: (2014)

Laser-generated functional nanoparticle bioconjugates: design for application in biomedical science and reproductive biology
por: Barchanski, Annette
Publicado: (2016)

Clonal expansion of CD8(+) T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI
por: Schultze-Florey, Christian R., et al.
Publicado: (2021)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up
por: Shahswar, Rabia, et al.
Publicado: (2020)

miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantation
por: Verma, Kriti, et al.
Publicado: (2017)

Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow
por: Engel, Nils W., et al.
Publicado: (2020)

Lentivirus-mediated antagomir expression for specific inhibition of miRNA function
por: Scherr, Michaela, et al.
Publicado: (2007)

Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
por: Scherr, Michaela, et al.
Publicado: (2018)

Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology
por: Baier, Claas, et al.
Publicado: (2018)

miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo
por: Lee, Chun-Wei, et al.
Publicado: (2018)

Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial
por: Gaidzik, Verena I., et al.
Publicado: (2023)

Genetic Deletion of SEPT7 Reveals a Cell Type-Specific Role of Septins in Microtubule Destabilization for the Completion of Cytokinesis
por: Menon, Manoj B., et al.
Publicado: (2014)

Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase
por: Schoenherr, Caroline, et al.
Publicado: (2019)

The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells
por: Martinez, Natalia, et al.
Publicado: (2004)

Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin
por: Teich, Katrin, et al.
Publicado: (2021)

Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
por: Kamp, Jan C., et al.
Publicado: (2021)

Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia
por: Zaliova, Marketa, et al.
Publicado: (2020)

Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart
por: Kirchhoff, Hanna, et al.
Publicado: (2022)

RNA-Mediated Gene Silencing in Hematopoietic Cells
por: Venturini, Letizia, et al.
Publicado: (2006)

Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation
por: Bialek-Waldmann, Julia K., et al.
Publicado: (2019)

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
por: Berger, Raffaela S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iufi0npimb2cscmejhts8tldh3